Results 111 to 120 of about 9,597 (210)

Cholera prevention and control in Asian countries

BMC Proceedings, 2018
Cholera remains a major public health problem in many countries. Poor sanitation and inappropriate clean water supply, insufficient health literacy and community mobilization, absence of national plans and cross-border collaborations are major factors ...
Mesbah Uddin Ahmed, Mario Baquilod, Claudio Deola, Nguyen Dong Tu, Dang Duc Anh, Cindy Grasso, Anu Gautam, Wan Mansor Hamzah, Seng Heng, Sopon Iamsirithaworn, Musal Kadim, S. K. Kar, Mai Le Thi Quynh, Anna Lena Lopez, Julia Lynch, Iqbal Memon, Martin Mengel, Vu Ngoc Long, Basu Dev Pandey, Firdausi Quadri, Mitra Saadatian-Elahi, Sanjukta Sen Gupta, Ashraf Sultan, Dipika Sur, Dang Quang Tan, Hoang Thi Thu Ha, Nguyen Tran Hein, Phan Trong Lan, Shyam Raj Upreti, Hubert Endtz, N. K. Ganguly, Dominique Legros, Valentina Picot, G. Balakrish Nair   +33 more
doaj   +1 more source

The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study.

PLoS Medicine, 2019
BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burden reported in sub-Saharan Africa. In May 2018, the World Health Assembly committed to reducing worldwide cholera deaths by 90% by 2030.
Elizabeth C Lee, Andrew S Azman, Joshua Kaminsky, Sean M Moore, Heather S McKay, Justin Lessler   +5 more
doaj   +1 more source

Oral cholera vaccine [PDF]

, 2013
The present invention provides s DNA plasmid pVAX1 comprising coding sequences of the Vibrio cholerae genes ctxB, optionally encapsulated in alginate or cellulose acetate phthalate microspheres.
Shamsudin, Mariana Nor, Rosli, Rozita, Abdullah, Syahrilnizam, Hanafi, Aimi Melati, Nograles, Nadine   +4 more
core  

Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam

Bulletin of the World Health Organization, 2002
OBJECTIVE: To evaluate a killed oral cholera vaccine produced in Viet Nam, and to compare the Vietnamese vaccine with one that is licensed internationally.
Trach D.D., Cam P.D., Ke N.T., Rao M.R., Dinh D., Hang P.V., Hung N.V., Canh D.G., Thiem V.D., Naficy A., Ivanoff B., Svennerholm A-M., Holmgren J., Clemens J.D.   +13 more
doaj  

Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera [PDF]

, 2019
Young children, older children, and adults develop comparable levels and durations of immunity following cholera. In comparison, young children receiving oral killed cholera vaccines (OCV) develop a lower level and shorter duration of protection than ...
Rashu, Rasheduzzaman, Harris, Jason B., Weil, Ana A., Rahman, Mohammad Arif, Calderwood, Stephen B., Leung, Daniel T., Ryan, Edward T., Qadri, Firdausi, Hosen, M. Ismail, Charles, Richelle C., Arifuzzaman, Mohammad, Bhuiyan, M. Saruar, Bhuiyan, Taufiqur Rahman, Saha, Amit, Khanam, Farhana, LaRocque, Regina C., Clements, John D., Holmes, Randall K.   +17 more
core   +1 more source

Oral cholera vaccine given marketing authorisation in European Union [PDF]

, 2004
At the end of April 2004, the European Medicines Agency (EMEA, http://www.emea.eu.int) issued a marketing authorisation (comparable to a product licence) applicable to all European Union countries for the oral cholera vaccine Dukoral, produced by Chiron ...
Collective Editorial team
core   +1 more source

Biomodel for evaluating attenuated Vibrio cholerae strains as human cholera vaccine candidates. Study of toxigenicity, immunogenicity and protection

VacciMonitor, 2014
In many countries, Cholera remains being a problem for human health, since it continues being an epidemic or endemic disease, which affects either children or adults and it is a death cause when cholera cases are not treated.
Reynaldo Oliva-Hernández, Hilda María García-Sánchez, Juan Francisco Infante-Bourzac, José Luis Pérez- Quiñoy, Bárbara Cedré-Marrero, Tania Valmaseda-Pérez, Arturo Talavera-Coronel, Gemma Año-López, Viviana Margarita Pérez-Amat, Luís García-Imía   +9 more
doaj  

An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease. [PDF]

PLoS One, 2023
Meunier M, Spillmann A, Rousseaux C, Schwamborn K, Hanson M.   +4 more
europepmc   +1 more source

Vaccine [PDF]

Vaccination is a key intervention to prevent and control cholera in conjunction with water, sanitation and hygiene activities. An oral cholera vaccine (OCV) stockpile was established by the World Health Organization (WHO) in 2013.

core  

Therapeutic dendritic cell vaccination against human papillomavirus [PDF]

, 2009
Cervical cancer, which is caused by infection with human papillomavirus (HPV), is the second most common cancer among women worldwide, leading to 230000 deaths annually.
Nurkkala Karlsson, Merja
core